Efficacy and safety of upadacitinib for active ankylosing spondylitis refractory to biological therapy: a double-blind, randomised, placebo-controlled phase 3 trial.
Désirée Mfm van der HeijdeXenofon BaraliakosJoachim SieperAtul A DeodharRobert D InmanHideto KamedaXiaofeng ZengYunxia SuiXianwei BuAileen L PanganPeter WungIn-Ho SongPublished in: Annals of the rheumatic diseases (2022)
NCT04169373.